Skip to contentC
Cerenome, Inc.
C
CNSYCerenome, Inc. Q1 2014 · 10-Q
Revenue$1.03M$1.03M−25.9% vs Q1 2013 Net Income-$10.40M-$10.40MN/M vs Q1 2013 EPS Diluted-$0.14-$0.14N/M vs Q1 2013 Gross Profit$610,000−4.1% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Cerenome, Inc. · CIK 1095981 · Engraved from SEC EDGAR
Operating Cash Flow-$8,962,000N/M Free Cash Flowderived-$9,249,000N/M Margins · derivedGross margin59.2%+13.5 pt vs Q1 2013
Operating margin-926.0%−442.0 pt vs Q1 2013
Net margin-1008.7%−457.9 pt vs Q1 2013
ended Mar 31, 2014 · filed May 12, 2014 · 42 d after period end